These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
514 related articles for article (PubMed ID: 17537911)
1. Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers. Mani SA; Yang J; Brooks M; Schwaninger G; Zhou A; Miura N; Kutok JL; Hartwell K; Richardson AL; Weinberg RA Proc Natl Acad Sci U S A; 2007 Jun; 104(24):10069-74. PubMed ID: 17537911 [TBL] [Abstract][Full Text] [Related]
2. Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Taube JH; Herschkowitz JI; Komurov K; Zhou AY; Gupta S; Yang J; Hartwell K; Onder TT; Gupta PB; Evans KW; Hollier BG; Ram PT; Lander ES; Rosen JM; Weinberg RA; Mani SA Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15449-54. PubMed ID: 20713713 [TBL] [Abstract][Full Text] [Related]
3. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Yang J; Mani SA; Donaher JL; Ramaswamy S; Itzykson RA; Come C; Savagner P; Gitelman I; Richardson A; Weinberg RA Cell; 2004 Jun; 117(7):927-39. PubMed ID: 15210113 [TBL] [Abstract][Full Text] [Related]
4. FOXF2 deficiency promotes epithelial-mesenchymal transition and metastasis of basal-like breast cancer. Wang QS; Kong PZ; Li XQ; Yang F; Feng YM Breast Cancer Res; 2015 Feb; 17(1):30. PubMed ID: 25848863 [TBL] [Abstract][Full Text] [Related]
5. FOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancer. Hollier BG; Tinnirello AA; Werden SJ; Evans KW; Taube JH; Sarkar TR; Sphyris N; Shariati M; Kumar SV; Battula VL; Herschkowitz JI; Guerra R; Chang JT; Miura N; Rosen JM; Mani SA Cancer Res; 2013 Mar; 73(6):1981-92. PubMed ID: 23378344 [TBL] [Abstract][Full Text] [Related]
6. FOXF2 suppresses the FOXC2-mediated epithelial-mesenchymal transition and multidrug resistance of basal-like breast cancer. Cai J; Tian AX; Wang QS; Kong PZ; Du X; Li XQ; Feng YM Cancer Lett; 2015 Oct; 367(2):129-37. PubMed ID: 26210254 [TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of serine 367 of FOXC2 by p38 regulates ZEB1 and breast cancer metastasis, without impacting primary tumor growth. Werden SJ; Sphyris N; Sarkar TR; Paranjape AN; LaBaff AM; Taube JH; Hollier BG; Ramirez-Peña EQ; Soundararajan R; den Hollander P; Powell E; Echeverria GV; Miura N; Chang JT; Piwnica-Worms H; Rosen JM; Mani SA Oncogene; 2016 Nov; 35(46):5977-5988. PubMed ID: 27292262 [TBL] [Abstract][Full Text] [Related]
8. LARP7 suppresses P-TEFb activity to inhibit breast cancer progression and metastasis. Ji X; Lu H; Zhou Q; Luo K Elife; 2014 Jul; 3():e02907. PubMed ID: 25053741 [TBL] [Abstract][Full Text] [Related]
9. HGF and TGFβ1 differently influenced Wwox regulatory function on Twist program for mesenchymal-epithelial transition in bone metastatic versus parental breast carcinoma cells. Bendinelli P; Maroni P; Matteucci E; Desiderio MA Mol Cancer; 2015 Jun; 14():112. PubMed ID: 26041563 [TBL] [Abstract][Full Text] [Related]
10. Prognostic role of Twist, Slug, and Foxc2 expression in stage I non-small-cell lung cancer after curative resection. Jiang W; Pang XG; Wang Q; Shen YX; Chen XK; Xi JJ Clin Lung Cancer; 2012 Jul; 13(4):280-7. PubMed ID: 22178381 [TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of epithelial-mesenchymal transition proteins Twist and Foxc2 in phyllodes tumours of the breast. Lim JC; Koh VC; Tan JS; Tan WJ; Thike AA; Tan PH Breast Cancer Res Treat; 2015 Feb; 150(1):19-29. PubMed ID: 25677742 [TBL] [Abstract][Full Text] [Related]
12. Breast cancer metastasis suppressor 1 (BRMS1) attenuates TGF-β1-induced breast cancer cell aggressiveness through downregulating HIF-1α expression. Cho KH; Yu SL; Cho DY; Park CG; Lee HY BMC Cancer; 2015 Oct; 15():829. PubMed ID: 26520789 [TBL] [Abstract][Full Text] [Related]
13. Correlation of Forkhead Box c2 with subtypes and invasive ability of invasive breast cancer. Dai J; Wang JY; Yang LL; Xiao Y; Qu ZL; Qin SH; Ruan QR J Huazhong Univ Sci Technolog Med Sci; 2014 Dec; 34(6):896-901. PubMed ID: 25480587 [TBL] [Abstract][Full Text] [Related]
14. Relationship between circulating tumor cells and epithelial to mesenchymal transition in early breast cancer. Mego M; Cierna Z; Janega P; Karaba M; Minarik G; Benca J; Sedlácková T; Sieberova G; Gronesova P; Manasova D; Pindak D; Sufliarsky J; Danihel L; Reuben JM; Mardiak J BMC Cancer; 2015 Jul; 15():533. PubMed ID: 26194471 [TBL] [Abstract][Full Text] [Related]
15. Forkhead transcription factor foxq1 promotes epithelial-mesenchymal transition and breast cancer metastasis. Zhang H; Meng F; Liu G; Zhang B; Zhu J; Wu F; Ethier SP; Miller F; Wu G Cancer Res; 2011 Feb; 71(4):1292-301. PubMed ID: 21285253 [TBL] [Abstract][Full Text] [Related]
16. Nuclear localization of GLI1 and elevated expression of FOXC2 in breast cancer is associated with the basal-like phenotype. Li Y; Yang W; Yang Q; Zhou S Histol Histopathol; 2012 Apr; 27(4):475-84. PubMed ID: 22374725 [TBL] [Abstract][Full Text] [Related]
17. Identifying biomarkers of breast cancer micrometastatic disease in bone marrow using a patient-derived xenograft mouse model. Pillai SG; Li S; Siddappa CM; Ellis MJ; Watson MA; Aft R Breast Cancer Res; 2018 Jan; 20(1):2. PubMed ID: 29291741 [TBL] [Abstract][Full Text] [Related]
18. Twist1 promotes breast cancer invasion and metastasis by silencing Foxa1 expression. Xu Y; Qin L; Sun T; Wu H; He T; Yang Z; Mo Q; Liao L; Xu J Oncogene; 2017 Feb; 36(8):1157-1166. PubMed ID: 27524420 [TBL] [Abstract][Full Text] [Related]
20. Overexpressed FOXC2 in ovarian cancer enhances the epithelial-to-mesenchymal transition and invasion of ovarian cancer cells. Liu B; Han SM; Tang XY; Han L; Li CZ Oncol Rep; 2014 Jun; 31(6):2545-54. PubMed ID: 24700112 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]